Reasons for discontinuing intracavernous injection therapy with prostaglandin E 1 (alprostadil)

Autor: Lehmann, K *, Casella, R, Blöchlinger, A, Gasser, T.C
Zdroj: In Urology 1999 53(2):397-400
Databáze: ScienceDirect